{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T04:03:53Z","timestamp":1768017833186,"version":"3.49.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>\n                    Iodine-131 (\n                    <jats:sup>131<\/jats:sup>\n                    I) is a common therapy for treatment of differentiated thyroid carcinoma (DTC); however, its radioactivity poses a radiation safety risk to public health. There is inter-facility variation in release instructions to minimize incident exposure to other individuals. Isolation measures are not without harm. Most studies on this topic rely upon cumulative dosimetry to measure exposure, but this does not provide the researcher with critical dose protraction information. Refining estimation of elimination kinetics with more frequent exposure readings would help optimize radiation safety recommendations. Measuring radiation exposure from patients with DTC post-thyroidectomy receiving\n                    <jats:sup>131<\/jats:sup>\n                    I would better quantify its elimination kinetics to improve radiation safety recommendations. Patients with DTC post-thyroidectomy undergoing radioiodine remnant ablation with\n                    <jats:sup>131<\/jats:sup>\n                    I were instructed to measure exposure at a distance of 1\u2009m, three times a day for 14\u2009d, using an ion chamber at home. These data were used to form an exponential decay model and estimate the time after which cumulative exposure is below a reasonably low threshold. The average effective half-life was 15.8\u2009h when calculated using real-time exposure readings from 32 patients. Among patients administered less than 4.22\u2009GBq, cumulative effective dose is \u22641 mSv after 24\u2009h of isolation. Between 4.22 and 6.03\u2009GBq, cumulative effective dose is \u22641mSv after 48\u2009h of isolation. Cumulative gamma radiation exposure at 1\u2009m remains low enough to consider re-evaluating isolation protocols that encourage long-term distancing past the first 24\u2009h in post-thyroidectomy patients treated with\n                    <jats:sup>131I<\/jats:sup>\n                    for remnant ablation.\n                  <\/jats:p>","DOI":"10.1097\/hp.0000000000001997","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T11:00:40Z","timestamp":1748862040000},"page":"57-64","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Measurement of Effective Half-life of Iodine-131 to Optimize Safety Release Instructions after Treatment for Patients with Differentiated Thyroid Cancer"],"prefix":"10.1097","volume":"130","author":[{"given":"Timothy","family":"Greist","sequence":"first","affiliation":[{"name":"Ascension St. Vincent Hospital, 2001 West 86th Street, Indianapolis IN, 46260"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Smith","sequence":"additional","affiliation":[{"name":"Indiana University School of Medicine, Division of Endocrinology, 1120 W. Michigan Street, Gatch Hall 380, Indianapolis, IN 46202."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"bib1-20260109","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4158\/EP.6.1.37","article-title":"Radioiodine uptake in the head and neck.","volume":"6","author":"Bakheet","year":"2000","journal-title":"Endocr Pract"},{"key":"bib4-20260109","doi-asserted-by":"crossref","first-page":"13761","DOI":"10.1073\/pnas.2235592100","article-title":"Cancer risks attributable to low doses of ionizing radiation: assessing what we really know.","volume":"100","author":"Brenner","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"bib5-20260109","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/s41562-022-01453-0","article-title":"Social isolation and the brain in the pandemic era.","volume":"6","author":"Bzdok","year":"2022","journal-title":"Nat Hum Behav"},{"key":"bib6-20260109","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/1450-1147.203078","article-title":"An evaluation of deviation from the International Atomic Energy Agency-International Commission on Radiological Protection proposed equation for calculation of radiation dose rate emanating from the patients with differentiated thyroid cancer undergoing radioiodine (I-131) therapy.","volume":"16","author":"Dehkordi","year":"2017","journal-title":"World J Nucl Med"},{"key":"bib7-20260109","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/MNM.0b013e328347f1c2","article-title":"Radiation doses to cohabitants of patients undergoing radioiodine ablation for thyroid cancer: poor compliance with radiation protection guidelines but low radiation exposure.","volume":"32","author":"Gabriel","year":"2011","journal-title":"Nucl Med Commun"},{"key":"bib8-20260109","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/jama.1971.03190030061017","article-title":"New normal values for thyroid uptake of radioactive iodine.","volume":"217","author":"Ghahremani","year":"1971","journal-title":"JAMA"},{"key":"bib9-20260109","first-page":"1288","article-title":"Normal 131-iodine uptake values at 2 and 24\u2009hours.","volume":"136","author":"Gonzalez","year":"2008","journal-title":"Rev Med Chil"},{"key":"bib10-20260109","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bbi.2020.05.040","article-title":"Mental health consequences during the initial stage of the 2020 coronavirus pandemic (COVID-19) in Spain.","volume":"87","author":"Gonz\u00e1lez-Sanguino","year":"2020","journal-title":"Brain Behav Immun"},{"key":"bib11-20260109","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1001\/jama.283.17.2272","article-title":"Radiation exposure from outpatient radioactive iodine (131I) therapy for thyroid carcinoma.","volume":"283","author":"Grigsby","year":"2000","journal-title":"JAMA"},{"key":"bib12-20260109","doi-asserted-by":"crossref","first-page":"A29","DOI":"10.1088\/0952-4746\/29\/2A\/S03","article-title":"Human exposure to high natural background radiation: what can it teach us about radiation risks?","volume":"29","author":"Hendry","year":"2009","journal-title":"J Radiol Prot"},{"key":"bib13-20260109","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/1745691614568352","article-title":"Loneliness and social isolation as risk factors for mortality: a meta-analytic review.","volume":"10","author":"Holt-Lunstad","year":"2015","journal-title":"Perspect Psychol Sci"},{"key":"bib18-20260109","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4103\/0972-3919.72686","article-title":"Estimation of effective half-life of clearance of radioactive iodine (131I) in patients treated for hyperthyroidism and carcinoma thyroid.","volume":"25","author":"Ravichandran","year":"2010","journal-title":"Indian J Nucl Med"},{"key":"bib19-20260109","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev-physiol-022516-034125","article-title":"The sodium\/iodide symporter (NIS): molecular physiology and preclinical and clinical applications.","volume":"79","author":"Ravera","year":"2017","journal-title":"Annu Rev Physiol"},{"key":"bib20-20260109","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1007\/s00259-002-0877-3","article-title":"Radioiodine therapy in Graves' disease based on tissue-absorbed dose calculations: effect of pre-treatment volume on clinical outcome.","volume":"29","author":"Reinhardt","year":"2002","journal-title":"Eur J Nucl Med"},{"key":"bib21-20260109","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ejso.2007.02.034","article-title":"Evaluation of the surgical completeness after total thyroidectomy for differentiated thyroid carcinoma.","volume":"33","author":"Salvatori","year":"2007","journal-title":"Eur J Surg Oncol"},{"key":"bib22-20260109","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1089\/thy.2009.0455","article-title":"The effectiveness of radioactive iodine for treatment of low-risk thyroid cancer: a systematic analysis of the peer-reviewed literature from 1966 to April 2008.","volume":"20","author":"Sacks","year":"2010","journal-title":"Thyroid"},{"key":"bib23-20260109","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1089\/thy.2010.0403","article-title":"Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I: practice recommendations of the American Thyroid Association.","volume":"21","author":"Sisson","year":"2011","journal-title":"Thyroid"},{"key":"bib24-20260109","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.clon.2016.01.007","article-title":"Radiation exposure and health effects\u2014is it time to reassess the real consequences?","volume":"28","author":"Thomas","year":"2016","journal-title":"Clin Oncol"},{"key":"bib30-20260109","first-page":"541","article-title":"Measurement of the dose to the family members taking care of thyroid cancer patients undergoing I-131 therapy in nuclear medicine using TLD-100.","volume":"174","author":"Zehtabian","year":"2017","journal-title":"Radiat Protect Dosim"}],"container-title":["Health Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HP.0000000000001997","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T21:00:21Z","timestamp":1767992421000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/HP.0000000000001997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/hp.0000000000001997","relation":{},"ISSN":["0017-9078","1538-5159"],"issn-type":[{"value":"0017-9078","type":"print"},{"value":"1538-5159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]}}}